Literature DB >> 29861515

Monitoring HIV Drug Resistance: Early Warning Indicators to Assess Performance of Thailand's Antiretroviral Treatment Program.

Cheewanan Lertpiriyasuwat1, Achara Teeraratkul2, Yolsilp Suchonwanich3, Nartlada Chatharojwong2, Kunjanakorn Phokasawad2, Porntip Yuktanon1, Naparat Pattarapayoon1, Sorakij Bhakeecheep3, Silvia Bertagnolio4, Thierry H Roels2, Sombat Thanprasertsuk5.   

Abstract

OBJECTIVE: To describe trends in Thailand's antiretroviral treatment (ART) program performance assessed by HIV drug resistance early warning indicators (EWIs), as recommended by WHO, between 2009 and 2013. MATERIAL AND
METHOD: Seven EWIs were monitored, viral load (VL) testing coverage, VL suppression, retention in ART, lost to follow-up (LTFU), antiretrovirals (ARVs) dispensing practices, on-time pill pick-up, and pharmacy stock-outs. Data from ART adult patients in National Health Security Office Scheme were analyzed except for pharmacy stock-outs, which were reported from hospitals. Aggregated averages were calculated for each EWI. Chi-square for trend was applied to measure significant changes.
RESULTS: By September 2013, 174,284 adults were receiving ART at 929 hospitals. Over time, improvement in VL testing coverage (53.8% in 2009 to 79.8% in 2013) was observed. VL suppression and on-time pill pick up rates were well above 90%. Rates of retention in ART declined from 84.0 to 82.9%, whereas LTFU rates increased from 8.3 to 9.2% (p<0.001). Prescriptions with inappropriate ARVs decreased from 0.32 to 0.10% (p<0.001). Of reporting hospitals, 96.1%, 96.3%, and 96.2% observed no ARVs stock-out between 2011 and 2013.
CONCLUSION: EWI is a useful tool to monitor ART program performance and to identify area where improvement is needed.

Entities:  

Keywords:  Antiretroviral treatment; Drug resistance; Early warning indicator; HIV; Thailand

Mesh:

Substances:

Year:  2017        PMID: 29861515      PMCID: PMC5978419     

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  11 in total

1.  Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011.

Authors:  M R Jordan; D E Bennett; M A Wainberg; D Havlir; S Hammer; C Yang; L Morris; M Peeters; A M Wensing; N Parkin; J B Nachega; A Phillips; A De Luca; E Geng; A Calmy; E Raizes; P Sandstrom; C P Archibald; J Perriëns; C M McClure; S Y Hong; J H McMahon; N Dedes; D Sutherland; S Bertagnolio
Journal:  Clin Infect Dis       Date:  2012-05       Impact factor: 9.079

2.  The National Access to Antiretroviral Program for PHA (NAPHA) in Thailand.

Authors:  Sanchai Chasombat; Cheewanan Lertpiriyasuwat; Sombat Thanprasertsuk; Laksami Suebsaeng; Ying Ru Lo
Journal:  Southeast Asian J Trop Med Public Health       Date:  2006-07       Impact factor: 0.267

3.  Genotypic resistance mutations in treatment-naïve and treatment-experienced patients under widespread use of antiretroviral drugs in Thailand: implications for further epidemiologic surveillance.

Authors:  Chonlaphat Sukasem; Vina Churdboonchart; Kanjana Sirisidthi; Suda Riengrojpitak; Sanchai Chasombat; Chotip Watitpun; Wantanich Piroj; Montip Tiensuwan; Wasun Chantratita
Journal:  Jpn J Infect Dis       Date:  2007-09       Impact factor: 1.362

4.  The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.

Authors:  Diane E Bennett; Silvia Bertagnolio; Donald Sutherland; Charles F Gilks
Journal:  Antivir Ther       Date:  2008

5.  HIV-1 drug resistance-associated mutations among antiretroviral-naive Thai patients with chronic HIV-1 infection.

Authors:  Weerawat Manosuthi; Supeda Thongyen; Samruay Nilkamhang; Sukanya Manosuthi; Somnuek Sungkanuparph
Journal:  J Med Virol       Date:  2012-11-14       Impact factor: 2.327

6.  Combining cohort analysis and monitoring of HIV early-warning indicators of drug resistance to assess antiretroviral therapy services in Vietnam.

Authors:  Thi Nhan Do; Thi Minh Thu Nguyen; Mai Hoa Do; Kato Masaya; Thi Bich Dang; Thuy Linh Pham; Kayoko Yoshikawa; Thi Than Thuy Cao; Thi Thuy Van Nguyen; Duc Duong Bui; Van Kinh Nguyen; Thanh Long Nguyen; Masami Fujita
Journal:  Clin Infect Dis       Date:  2012-05       Impact factor: 9.079

7.  Antiretroviral drug resistance among antiretroviral-naïve persons with recent HIV infection in Thailand.

Authors:  A Apisarnthanarak; T Jirayasethpong; C Sa-nguansilp; H Thongprapai; C Kittihanukul; A Kamudamas; A Tungsathapornpong; L M Mundy
Journal:  HIV Med       Date:  2008-05       Impact factor: 3.180

8.  National expansion of antiretroviral treatment in Thailand, 2000-2007: program scale-up and patient outcomes.

Authors:  Sanchai Chasombat; Michelle S McConnell; Umaporn Siangphoe; Porntip Yuktanont; Thidaporn Jirawattanapisal; Kimberley Fox; Sombat Thanprasertsuk; Philip A Mock; Peeramon Ningsanond; Cheewanan Lertpiriyasuwat; Somchai Pinyopornpanich
Journal:  J Acquir Immune Defic Syndr       Date:  2009-04-15       Impact factor: 3.731

9.  Early warning indicators for HIV drug resistance in Cameroon during the year 2010.

Authors:  Serge C Billong; Joseph Fokam; Armand S Nkwescheu; Etienne Kembou; Pascal Milenge; Zephirin Tsomo; Grace Ngute Dion; Avelin F Aghokeng; Eitel N Mpoudi; Peter M Ndumbe; Vittorio Colizzi; Jean B Elat Nfetam
Journal:  PLoS One       Date:  2012-05-17       Impact factor: 3.240

10.  Emergence of HIV-1 drug resistance mutations among antiretroviral-naïve HIV-1-infected patients after rapid scaling up of antiretroviral therapy in Thailand.

Authors:  Somnuek Sungkanuparph; Chonlaphat Sukasem; Sasisopin Kiertiburanakul; Ekawat Pasomsub; Wasun Chantratita
Journal:  J Int AIDS Soc       Date:  2012-03-12       Impact factor: 5.396

View more
  1 in total

1.  Programme quality indicators of HIV drug resistance among adolescents in urban versus rural settings of the centre region of Cameroon.

Authors:  Joseph Fokam; Armanda Nangmo; Carlson Wandum; Desire Takou; Maria Mercedes Santoro; Anne-Esther Njom Nlend; Francis Ndongo Ateba; Paul Koki Ndombo; Nelly Kamgaing; Cedric Kamta; Andre Essiane; Virginie Lambo; Charles Fokunang; Dora Mbanya; Vittorio Colizzi; Carlo-Federico Perno; Alexis Ndjolo
Journal:  AIDS Res Ther       Date:  2020-05-12       Impact factor: 2.250

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.